Evidence map›Paper›PMID 42123087›Full record

ArticleJournal of clinical medicine2026

Serum Transthyretin as a Prognostic and Therapeutic Biomarker in Transthyretin Amyloid Cardiomyopathy Patients Treated with Tafamidis.

Jacopo Costantino, Federico Ballatore, Giulia Marchionni, Maria Alfarano, Silvia Stavagna, Samuel Costantino, Carmine Dario Vizza, Cristina Chimenti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jacopo CostantinoDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Federico BallatoreDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0009-0002-5061-0424
Giulia MarchionniDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-4311-7570
Maria AlfaranoDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Silvia StavagnaDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Samuel CostantinoDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Carmine Dario VizzaDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-3540-4983
Cristina ChimentiDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersprognosisserum transthyretintafamidistransthyretin amyloid cardiomyopathy

Identifiers

PMID42123087
PMCPMC13164462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.